Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byEisai
Price$255M
Date1/2010

General Information

CategoryBioTech
Phone201-909-3000
Employees
Founded2005

Offices

Paramus, USA
Mack Centre IV
4th Floor
Paramus, NJ, 07652
USA

People

Funding

TOTAL $26.1M
FUNDING TOTAL $26.1M
Venture Round, 1/2010
InterWest Partners
Sutter Hill Ventures
$26.1M

Tags

AkaRx

AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Recent Milestones

Videos

Screenshots

Sources

  1. Eisai Completes Acquisition of AkaRx, Inc. in the United States (eisai.co.jp) [edit]
  2. Eisai's $255M AkaRx Buy Creates Returns For InterWest, Sutter Hill (fis.dowjones.com) [edit]
Edit This Page
Last Edited 1/13/10

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy